C07K

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
8,808,666 Peptides that specifically target amyloid deposits Sep 26, 12 Aug 19, 14 , UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
8,808,679 Auristatin compounds and conjugates thereof Jul 17, 13 Aug 19, 14 , MERSANA THERAPEUTICS, INC.
8,808,697 Methods of use of soluble CD24 for therapy of rheumatoid arthritis Apr 28, 11 Aug 19, 14 , ONCOIMMUNE, INC.
8,808,700 Use of TNF alpha inhibitor for treatment of erosive polyarthritis Mar 28, 14 Aug 19, 14 , ABBVIE BIOTECHNOLOGY LTD.
8,808,701 Methods of inhibiting the interaction of C5aR with C5a with anti-C5aR antibodies Dec 19, 12 Aug 19, 14 , G2 INFLAMMATION PTY LTD
8,808,705 Polyvalent chimeric OspC vaccinogen and diagnostic antigen Oct 19, 11 Aug 19, 14 , VIRGINIA COMMONWEALTH UNIVERSITY
8,808,999 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof Jan 18, 12 Aug 19, 14 , PIERRE FABRE MEDICAMENT
8,809,000 Methods of screening heteromeric T1R2/T1R3 receptors for compounds which modulate sweet taste signaling Jan 24, 12 Aug 19, 14 , SENOMYX INC.
8,809,002 MUC1, caspase-8, and DED-containing proteins Jul 09, 09 Aug 19, 14 , DANA-FARBER CANCER INSTITUTE, INC.
8,809,004 Detection of feline immunodeficiency virus Apr 01, 11 Aug 19, 14 , IDEXX LABORATORIES, INC.
8,809,005 Conjugate and its use as a standard in an immunoassay Nov 16, 07 Aug 19, 14 , HOFFMANN-LA ROCHE INC.
8,809,047 Herpes simplex virus vaccines Dec 20, 10 Aug 19, 14 , THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
8,809,060 Ethanol-resistant yeast gene, and use thereof Nov 24, 10 Aug 19, 14 , EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
8,809,257 Compositions and methods for promoting wound healing and tissue regeneration Dec 14, 12 Aug 19, 14 , MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
8,809,258 Method for producing peptide Jul 30, 08 Aug 19, 14 , GLYTECH INC.
8,809,259 Charged nutritive proteins and methods Mar 15, 13 Aug 19, 14 , PRONUTRIA, INC.
8,809,260 β-arrestin effectors and compositions and methods of use thereof Jun 24, 13 Aug 19, 14 , TREVENA, INC.
8,809,271 Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jun 29, 12 Aug 19, 14 , RANI THERAPEUTICS, LLC
8,809,275 Peptoids and methods for treating alzheimer's disease Oct 19, 12 Aug 19, 14 , THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS; UNIVERSITY OF SOUTH CAROLINA;
8,809,276 Activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same Feb 17, 12 Aug 19, 14 , ISP INVESTMENTS INC.

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2014/0227,172 DIAGNOSIS AND TREATMENT OF PROSTATE CANCER Mar 22, 12 Aug 14, 14 THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK,
2014/0227,178 Humanized Anti-HLA-DR Antibodies Mar 25, 14 Aug 14, 14 IMMUNOMEDICS, INC.,
2014/0227,223 Pegylated Interleukin-10 Feb 21, 14 Aug 14, 14 MERCK SHARP & DOHME CORP.,
2014/0227,238 PEPTIDES HAVING PROTECTIVE EFFECT TOWARDS THE INFLAMMATORY ACTIVITY OF PEPTIDE 31-43 OF A-GLIADIN IN CELIAC DISEASE Sep 18, 12 Aug 14, 14 CRA-SONSIGLIO PER LA RICERCA E LA,
2014/0227,250 STABLE FORMULATIONS OF ANTIBODIES TO TSLP Aug 21, 13 Aug 14, 14 MERCK SHARP & DOHME CORP.,
2014/0227,251 METHODS FOR IDENTIFYING ANTIBODIES WITH REDUCED IMMUNOGENICITY Sep 18, 13 Aug 14, 14 ABBVIE BIOTHERAPEUTICS INC.,
2014/0227,252 Methods and Monitoring of Treatment with a DLL4 Antagonist Oct 31, 13 Aug 14, 14 ONCOMED PHARMACEUTICALS, INC.,
2014/0227,253 Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof Nov 19, 13 Aug 14, 14 ROCHE GLYCART AG,
2014/0227,254 ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF Dec 27, 13 Aug 14, 14 ACCELERON PHARMA INC.,
2014/0227,256 Predictive biomarker for cancer treatment with ADCC-enhanced antibodies Jan 21, 14 Aug 14, 14 ROCHE GLYCART AG,
2014/0227,257 Monoclonal Antibodies that Neutralize Anthrax Protective Antigen (PA) Toxin Feb 14, 14 Aug 14, 14 ,
2014/0227,258 HUMANIZED ANTI-CMET ANTAGONISTS Mar 14, 14 Aug 14, 14 ,
2014/0227,259 MODIFIED PROTEINS AND PEPTIDES Aug 13, 12 Aug 14, 14 ,
2014/0227,263 USE OF FGFR1 EXTRA CELLULAR DOMAIN PROTEINS TO TREAT CANCERS CHARACTERIZED BY LIGAND-DEPENDENT ACTIVATING MUTATIONS IN FGFR2 Nov 14, 13 Aug 14, 14 ,
2014/0227,264 DRUG FUSIONS AND CONJUGATES WITH EXTENDED HALF LIFE Nov 18, 13 Aug 14, 14 GLAXO GROUP LIMITED,
2014/0227,265 METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING CLEC-2 Jun 18, 12 Aug 14, 14 AMGEN INC.,
2014/0227,266 NOGO Receptor Antagonists Jan 02, 14 Aug 14, 14 BIOGEN IDEC MA INC.,
2014/0227,267 BOVINE FUSION ANTIBODIES Jan 10, 14 Aug 14, 14 THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH,
2014/0227,268 AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC-ASGPR) Apr 16, 14 Aug 14, 14 BAYLOR RESEARCH INSTITUTE,
2014/0227,269 THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS Apr 22, 14 Aug 14, 14 UNIVERSITY OF WASHINGTON,

more results

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

UPGRADE MEMBERSHIP CANCEL